Therapeutic activity of DCC-2036, a novel tyrosine kinase inhibitor, against triple-negative breast cancer patient-derived xenografts by targeting AXL/MET
新型酪氨酸激酶抑制剂 DCC-2036 通过靶向 AXL/MET 对三阴性乳腺癌患者异种移植瘤的治疗活性
期刊:International Journal of Cancer
影响因子:5.7
doi:10.1002/ijc.31915
Yingying Shen, Wei Zhang, Jianghua Liu, Jun He, Renxian Cao, Xiguang Chen, Xiuda Peng, Haifan Xu, Qiang Zhao, Jing Zhong, Wenjun Ding, Xiaoyong Lei, Yuyang Jiang, Xuyu Zu